Table of Contents

September 9, 2004
Volume 47, Issue 19
Pages 4633-4798

About the Cover: RRibbon rendered illustration of the nuclear receptor heterodimer RXRα(cyan):PPARRγ (red) ligand binding domains bound with coactivator peptides (magenta) and agonist ligands (space-filling atoms where green is carbon, red is oxygen, and blue is nitrogen) (Haffner, C. D.; et al. J. Med. Chem. 2004, 47, 2010-2029).

Miniperspective

Virulence Regulation and Quorum Sensing in Staphylococcal Infections:  Competitive AgrC Antagonists as Quorum Sensing Inhibitors

pp 4633–4641
Publication Date (Web): July 16, 2004 (Perspective)
DOI: 10.1021/jm0400754

Letters

Potent and Orally Bioavailable Non-Peptide Antagonists at the Human Bradykinin B1 Receptor Based on a 2-Alkylamino-5-sulfamoylbenzamide Core

pp 4642–4644
Publication Date (Web): August 10, 2004 (Letter)
DOI: 10.1021/jm049747g

Discovery of Novel Heteroarylazoles That Are Metabotropic Glutamate Subtype 5 Receptor Antagonists with Anxiolytic Activity

pp 4645–4648
Publication Date (Web): August 14, 2004 (Letter)
DOI: 10.1021/jm049828c

In Vitro Cytotoxic Activities of 2-Alkyl-4,6-diheteroalkyl-1,3,5-triazines:  New Molecules in Anticancer Research

pp 4649–4652
Publication Date (Web): August 12, 2004 (Letter)
DOI: 10.1021/jm0495374

Articles

Fuzzy Pharmacophore Models from Molecular Alignments for Correlation-Vector-Based Virtual Screening

pp 4653–4664
Publication Date (Web): August 11, 2004 (Article)
DOI: 10.1021/jm031139y

Structural Basis for the Potent Antisickling Effect of a Novel Class of Five-Membered Heterocyclic Aldehydic Compounds

pp 4665–4676
Publication Date (Web): August 06, 2004 (Article)
DOI: 10.1021/jm0498001

Indolebutylamines as Selective 5-HT1A Agonists

pp 4677–4683
Publication Date (Web): August 10, 2004 (Article)
DOI: 10.1021/jm040792y

Synthesis and Structure−Activity Relationship in a Class of Indolebutylpiperazines as Dual 5-HT1A Receptor Agonists and Serotonin Reuptake Inhibitors

pp 4684–4692
Publication Date (Web): August 10, 2004 (Article)
DOI: 10.1021/jm040793q

A Prodrug Approach toward the Development of Water Soluble Fluoroquinolones and Structure−Activity Relationships of Quinoline-3-carboxylic Acids

pp 4693–4709
Publication Date (Web): August 13, 2004 (Article)
DOI: 10.1021/jm0497895

Design and Synthesis of a Nitrogen Mustard Derivative Stabilized by Apo-neocarzinostatin

pp 4710–4715
Publication Date (Web): August 17, 2004 (Article)
DOI: 10.1021/jm040790d

N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy

pp 4716–4730
Publication Date (Web): August 13, 2004 (Article)
DOI: 10.1021/jm040063i

CORES:  An Automated Method for Generating Three-Dimensional Models of Protein/Ligand Complexes

pp 4731–4740
Publication Date (Web): July 27, 2004 (Article)
DOI: 10.1021/jm0499054

Design, Synthesis, and Biological Evaluation of 1,2,3,7-Tetrahydro-6H-purin-6-one and 3,7-Dihydro-1H-purine-2,6-dione Derivatives as Corticotropin-Releasing Factor1 Receptor Antagonists

pp 4741–4754
Publication Date (Web): August 07, 2004 (Article)
DOI: 10.1021/jm049787k

Dipeptidomimetic Ketomethylene Isosteres as Pro-moieties for Drug Transport via the Human Intestinal Di-/Tripeptide Transporter hPEPT1:  Design, Synthesis, Stability, and Biological Investigations

pp 4755–4765
Publication Date (Web): August 10, 2004 (Article)
DOI: 10.1021/jm040780c

2-Pyrazolyl-N6-Substituted Adenosine Derivatives as High Affinity and Selective Adenosine A3 Receptor Agonists

pp 4766–4773
Publication Date (Web): August 07, 2004 (Article)
DOI: 10.1021/jm049682h

Synthesis and Biological Activity of Analogues of the Antimicrotubule Agent N,β,β-Trimethyl-l-phenylalanyl-N1-[(1S,2E)-3-carboxy-1-isopropylbut-2-enyl]- N1,3-dimethyl-l-valinamide (HTI-286)

pp 4774–4786
Publication Date (Web): August 03, 2004 (Article)
DOI: 10.1021/jm040056u

Design of 2,5-Dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and Structure−Activity Relationships of a Series of Potent and Orally Active Corticotropin-Releasing Factor Receptor Antagonists

pp 4787–4798
Publication Date (Web): August 06, 2004 (Article)
DOI: 10.1021/jm040058e